Elanco Animal Health (ELAN) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Elanco Animal Health Reports Second Quarter 2022 Results
August 8, 2022 6:30 AM EDTSecond Quarter 2022 Financial Results Revenue of $1,177 million Reported Net Loss of $22 million, Adjusted Net Income of $177 million Adjusted EBITDA of $300 million or 25.5% of Revenue Reported EPS of $(0.04), Adjusted EPS of $0.36 Updating full year 2022 guidance to reflect current assumptions related to economic, environmental and company-specific factors impacting the business, expecting: Revenue of $4,465 to $4,550 million Reported diluted EPS of $(0.10) to $(0.03), Adjusted EPS of $1.06 to $1.13 Reported Net Loss of $(48) to $(15) million, Adjusted... More
